{"created":"2023-06-20T15:47:33.016873+00:00","id":2088,"links":{},"metadata":{"_buckets":{"deposit":"52dbf628-7b99-433d-b6c3-e27270dade16"},"_deposit":{"created_by":4,"id":"2088","owners":[4],"pid":{"revision_id":0,"type":"depid","value":"2088"},"status":"published"},"_oai":{"id":"oai:hama-med.repo.nii.ac.jp:00002088","sets":["1:11"]},"author_link":["5584"],"item_3_biblio_info_5":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"1987-06-30","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"3","bibliographicPageEnd":"300","bibliographicPageStart":"293","bibliographicVolumeNumber":"10","bibliographic_titles":[{"bibliographic_title":"日本臨床免疫学会会誌"}]}]},"item_3_description_9":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"全身性エリテマトーデス(SLE)における抗体依存性細胞性細胞障害(ADCC)活性の異常の有無および疾患活動性,治療との関係につき検索し, SLEにおけるADCC活性の臨床的意義につき検討した. SLE患者リンパ球のADCC活性は疾患活動期に異常低値を示した. ADCC活性と流血中免疫複合体(CIC)の値との間には一定の関係を認めなかった. SLE患者血清は正常人リンパ球のADCC活性を抑制し,患者血清によるADCCの抑制の程度とCIC値との間に有意の相関(p<0.001)が認められた.また, SLE患者血清は,すでに低下しているSLE自己リンパ球のADCC活性をさらに有意(p<0.05)に低下させた. 以上のことより, SLE患者のADCC活性は,疾患活動性と密接に関係しており, ADCC活性の減弱は, Killer細胞自体の異常に加え, CICのごとき血清内因子によりin vivoではさらに減弱しているものと考えられた","subitem_description_type":"Abstract"}]},"item_3_publisher_6":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"日本臨床免疫学会"}]},"item_3_rights_7":{"attribute_name":"権利","attribute_value_mlt":[{"subitem_rights":"Copyright 日本臨床免疫学会"},{"subitem_rights":"本文データは学協会の許諾に基づきJournal Archiveから複製したものである"}]},"item_3_source_id_19":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"09114300","subitem_source_identifier_type":"ISSN"}]},"item_3_source_id_20":{"attribute_name":"EISSN","attribute_value_mlt":[{"subitem_source_identifier":"13497413","subitem_source_identifier_type":"ISSN"}]},"item_3_version_type_32":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"木佐森, 茂樹"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2018-08-27"}],"displaytype":"detail","filename":"JJClinImmunol10_3-294.pdf","filesize":[{"value":"424.4 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"JJClinImmunol10_3-294.pdf","url":"https://hama-med.repo.nii.ac.jp/record/2088/files/JJClinImmunol10_3-294.pdf"},"version_id":"41a92383-e3f5-4e3e-a86d-6a4601606a6f"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"systemic lupus erythematosus","subitem_subject_scheme":"Other"},{"subitem_subject":"antibody-dependent cell-mediated cytotoxicity","subitem_subject_scheme":"Other"},{"subitem_subject":"circulating immune complex","subitem_subject_scheme":"Other"},{"subitem_subject":"plasma exchange","subitem_subject_scheme":"Other"},{"subitem_subject":"killer cell","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"全身性エリテマトーデスにおけるADCC (K)細胞機能に関する研究","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"全身性エリテマトーデスにおけるADCC (K)細胞機能に関する研究","subitem_title_language":"ja"}]},"item_type_id":"3","owner":"4","path":["11"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2013-08-27"},"publish_date":"2013-08-27","publish_status":"0","recid":"2088","relation_version_is_last":true,"title":["全身性エリテマトーデスにおけるADCC (K)細胞機能に関する研究"],"weko_creator_id":"4","weko_shared_id":-1},"updated":"2023-08-02T04:31:23.177691+00:00"}